Pathway to Stop Diabetes Awardees Announced

Pathway to Stop Diabetes logoThe American Diabetes Association is excited to announce the first group of researchers who will receive grant support through Pathway to Stop Diabetes, the Association’s innovative research program which focuses on transformational approaches to ending this epidemic.

Pathway candidates were identified through nominations, where research institutions were asked to identify and put forward their most brilliant scientists proposing research relevant to any diabetes type, diabetes-related disease state or diabetes complication. Nominations included a broad range of disciplines, including medicine, biology, chemistry, engineering, physics and mathematics. These scientists, who are either just starting their careers in diabetes research, or are established in another field but want to expand their focus to diabetes research, were asked to propose creative and innovative ideas for diabetes research projects.

The 2013 Pathway Awards will provide funding for these innovative researchers:

  • Joshua Thaler, MD, PhD at the University of Washington, in Seattle, received a Pathway Accelerator Award for his basic research project entitled, “Modulating Glial-Neuronal Interactions to Treat Obesity And Diabetes”
  • Kathleen Page, MD at the University of Southern California, in Los Angeles, received a Pathway Accelerator Award for her translational research project entitled, “Neural Mechanisms in Maternal-Fetal Programming for Obesity and Diabetes”
  • Wolfgang Peti, PhD at Brown University’s Department of Molecular Pharmacology, Physiology and Biotechnology in Providence, R.I., received an Accelerator New to Diabetes Award for his project entitled, “Novel, Innovative Insights into Insulin Signaling and Regulation using NMR Spectroscopy”
  • Michael Dennis, PhD at Pennsylvania State University, in Hershey, Pa., received an Initiator Award for his basic research project entitled, “Hyperglycemia-Induced Translational Control of Gene Expression in the Retina”
  • Stephen Parker, PhD at the National Human Genome Research Institute in Bethesda, Md. received an Initiator Award for his basic research project entitled, “Deconstructing Type 2 Diabetes Using Genome-Wide High-Density Multi-Tissue ‘Omics’ Profiling”

Aiming to fund 100 new diabetes researchers over the next decade, Pathway is accelerating the research needed to discover solutions for this deadly disease. Pathway Awards will provide $1.625 million in research support for five to seven years for the selected investigators. The Pathway scientists will also receive ongoing mentorship from the Mentor Advisory Group, a distinguished group of researchers who selected the awardees and will continue to provide career and scientific guidance over the course of the award.

To learn more, visit

Tweet this post    Share on Facebook    Email this post
This entry was posted in About Us, Research, Stop Diabetes and tagged , , , , , . Bookmark the permalink.

One Response to Pathway to Stop Diabetes Awardees Announced

  1. jeffery says:

    Please find a cure.

Leave a Reply

Your email address will not be published. Required fields are marked *


This site uses Akismet to reduce spam. Learn how your comment data is processed.